138 related articles for article (PubMed ID: 22348173)
1. Recombinant human arginase toxicity in mice is reduced by citrulline supplementation.
Mauldin JP; Zeinali I; Kleypas K; Woo JH; Blackwood RS; Jo CH; Stone EM; Georgiou G; Frankel AE
Transl Oncol; 2012 Feb; 5(1):26-31. PubMed ID: 22348173
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of human recombinant arginase I (Co)-PEG5000 in the presence of supplemental L-citrulline is dependent on decreased argininosuccinate synthetase expression in human cells.
Agrawal V; Woo JH; Mauldin JP; Jo C; Stone EM; Georgiou G; Frankel AE
Anticancer Drugs; 2012 Jan; 23(1):51-64. PubMed ID: 21955999
[TBL] [Abstract][Full Text] [Related]
3. Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells.
Khoury O; Ghazale N; Stone E; El-Sibai M; Frankel AE; Abi-Habib RJ
J Neurooncol; 2015 Mar; 122(1):75-85. PubMed ID: 25567351
[TBL] [Abstract][Full Text] [Related]
4. Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells.
Tanios R; Bekdash A; Kassab E; Stone E; Georgiou G; Frankel AE; Abi-Habib RJ
Leuk Res; 2013 Nov; 37(11):1565-71. PubMed ID: 24018014
[TBL] [Abstract][Full Text] [Related]
5. Human Recombinant Arginase I [HuArgI (Co)-PEG5000]-Induced Arginine Depletion Inhibits Colorectal Cancer Cell Migration and Invasion.
Al-Koussa H; Al-Haddad M; Abi-Habib R; El-Sibai M
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795337
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of [HuArgI (co)-PEG5000]-induced arginine deprivation to ovarian Cancer cells is autophagy dependent.
Nasreddine G; El-Sibai M; Abi-Habib RJ
Invest New Drugs; 2020 Feb; 38(1):10-19. PubMed ID: 30887252
[TBL] [Abstract][Full Text] [Related]
7. Activation of autophagy following [HuArgI (Co)-PEG5000]-induced arginine deprivation mediates cell death in colon cancer cells.
Swayden M; Bekdash A; Fakhoury I; El-Atat O; Borjac-Natour J; El-Sibai M; Abi-Habib RJ
Hum Cell; 2021 Jan; 34(1):152-164. PubMed ID: 32979152
[TBL] [Abstract][Full Text] [Related]
8. [HuArgI (co)-PEG5000]-induced arginine deprivation leads to autophagy dependent cell death in pancreatic cancer cells.
Khalil N; Abi-Habib RJ
Invest New Drugs; 2020 Oct; 38(5):1236-1246. PubMed ID: 31823161
[TBL] [Abstract][Full Text] [Related]
9. Human Recombinant Arginase I [HuArgI(Co)-PEG5000]-Induced Arginine Depletion Inhibits Pancreatic Cancer Cell Migration and Invasion Through Autophagy.
El-Mais N; Fakhoury I; Al Haddad M; Nohra S; Abi-Habib R; El-Sibai M
Pancreas; 2021 Sep; 50(8):1187-1194. PubMed ID: 34714283
[TBL] [Abstract][Full Text] [Related]
10. Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion.
Cheng PN; Lam TL; Lam WM; Tsui SM; Cheng AW; Lo WH; Leung YC
Cancer Res; 2007 Jan; 67(1):309-17. PubMed ID: 17210712
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest.
Lam TL; Wong GK; Chong HC; Cheng PN; Choi SC; Chow TL; Kwok SY; Poon RT; Wheatley DN; Lo WH; Leung YC
Cancer Lett; 2009 May; 277(1):91-100. PubMed ID: 19138817
[TBL] [Abstract][Full Text] [Related]
12. Human recombinant arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits ovarian cancer cell adhesion and migration through autophagy-mediated inhibition of RhoA.
El-Mais N; Fakhoury I; Abdellatef S; Abi-Habib R; El-Sibai M
J Ovarian Res; 2021 Jan; 14(1):13. PubMed ID: 33423701
[TBL] [Abstract][Full Text] [Related]
13. Citrulline Supplementation Improves Organ Perfusion and Arginine Availability under Conditions with Enhanced Arginase Activity.
Wijnands KA; Meesters DM; van Barneveld KW; Visschers RG; Briedé JJ; Vandendriessche B; van Eijk HM; Bessems BA; van den Hoven N; von Wintersdorff CJ; Brouckaert P; Bouvy ND; Lamers WH; Cauwels A; Poeze M
Nutrients; 2015 Jun; 7(7):5217-38. PubMed ID: 26132994
[TBL] [Abstract][Full Text] [Related]
14. In-vivo evaluation of human recombinant Co-arginase against A375 melanoma xenografts.
Agrawal V; Woo JH; Mauldin JP; Stone EM; Meininger CJ; Jo C; Kleypas K; Frenkel EP; Frankel AE
Melanoma Res; 2014 Dec; 24(6):556-67. PubMed ID: 25304236
[TBL] [Abstract][Full Text] [Related]
15. Citrulline can preserve proliferation and prevent the loss of CD3 zeta chain under conditions of low arginine.
Bansal V; Rodriguez P; Wu G; Eichler DC; Zabaleta J; Taheri F; Ochoa JB
JPEN J Parenter Enteral Nutr; 2004; 28(6):423-30. PubMed ID: 15568289
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of arginase in rat and rabbit alveolar macrophages by N omega-hydroxy-D,L-indospicine, effects on L-arginine utilization by nitric oxide synthase.
Hey C; Boucher JL; Vadon-Le Goff S; Ketterer G; Wessler I; Racké K
Br J Pharmacol; 1997 Jun; 121(3):395-400. PubMed ID: 9179379
[TBL] [Abstract][Full Text] [Related]
17. L-Citrulline Supplementation Increases Plasma Nitric Oxide Levels and Reduces Arginase Activity in Patients With Type 2 Diabetes.
Shatanawi A; Momani MS; Al-Aqtash R; Hamdan MH; Gharaibeh MN
Front Pharmacol; 2020; 11():584669. PubMed ID: 33414716
[TBL] [Abstract][Full Text] [Related]
18. A bioengineered arginine-depleting enzyme as a long-lasting therapeutic agent against cancer.
Chung SF; Kim CF; Tam SY; Choi MC; So PK; Wong KY; Leung YC; Lo WH
Appl Microbiol Biotechnol; 2020 May; 104(9):3921-3934. PubMed ID: 32144472
[TBL] [Abstract][Full Text] [Related]
19. L-arginine uptake, the citrulline-NO cycle and arginase II in the rat brain: an in situ hybridization study.
Braissant O; Gotoh T; Loup M; Mori M; Bachmann C
Brain Res Mol Brain Res; 1999 Jul; 70(2):231-41. PubMed ID: 10407171
[TBL] [Abstract][Full Text] [Related]
20. Inability of rat alveolar macrophages to recycle L-citrulline to L-arginine despite induction of argininosuccinate synthetase mRNA and protein, and inhibition of nitric oxide synthesis by exogenous L-citrulline.
Hammermann R; Bliesener N; Mössner J; Klasen S; Wiesinger H; Wessler I; Racké K
Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):601-7. PubMed ID: 9879717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
